These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3805663)

  • 21. Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.
    Macfarlane PI; Miller V; Wells F; Richards B
    J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):93-6. PubMed ID: 3944748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis.
    Moran A; Jones A; Asquith P
    Scand J Gastroenterol; 1995 Apr; 30(4):356-60. PubMed ID: 7610352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early predictors of responses and clinical outcomes of corticosteroid treatment for severe ulcerative colitis.
    Han W; Xu JM; Hu NZ; Mei Q; Liu MW
    Scand J Gastroenterol; 2014 Apr; 49(4):424-33. PubMed ID: 24533622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.
    De Cassan C; Savarino E; Marson P; Tison T; Hatem G; Sturniolo GC; D'Incà R
    World J Gastroenterol; 2014 Dec; 20(45):17155-62. PubMed ID: 25493030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
    Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
    Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiol methyltransferase activity in inflammatory bowel disease.
    Roediger WE; Babidge WJ
    Gut; 2000 Aug; 47(2):206-10. PubMed ID: 10896911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
    Philipsen EK; Bondesen S; Andersen J; Larsen S
    Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
    Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
    Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on blood coagulation in ulcerative colitis and Crohn's disease.
    Mori K; Watanabe H; Hiwatashi N; Sugai K; Goto Y
    Tohoku J Exp Med; 1980 Sep; 132(1):93-101. PubMed ID: 7209972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment.
    Benazzato L; D'Incà R; Grigoletto F; Perissinotto E; Medici V; Angriman I; Sturniolo GC
    Dig Liver Dis; 2004 Jul; 36(7):461-6. PubMed ID: 15285525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholelithiasis in inflammatory bowel disease. A case-control study.
    Lorusso D; Leo S; Mossa A; Misciagna G; Guerra V
    Dis Colon Rectum; 1990 Sep; 33(9):791-4. PubMed ID: 2202567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of high risk factors for acute complex appendicitis in adults].
    Li S; Cheng L; Li Y; Ning L; Yu Z; Wang P; Zhou X; Ren J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1374-1379. PubMed ID: 30588588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease.
    Arber N; Berliner S; Hallak A; Bujanover Y; Dotan I; Liberman E; Santo M; Moshkowitz M; Ratan J; Dotan G
    Gut; 1995 Jul; 37(1):77-80. PubMed ID: 7672686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R
    Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: the management of mild to severe acute ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():88-92. PubMed ID: 15352901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple index for assessment of disease activity in patients with ulcerative colitis.
    Rutegård I; Ahsgren L; Stenling R; Nilsson T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():110-2. PubMed ID: 2083921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faecal analysis and plasma complement factor 3c levels at admission for an acute attack of ulcerative colitis are predictive of the need for colectomy.
    Pagoldh M; Lange S; Jennische E; Almer S; Boström EA; Eriksson A
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):295-300. PubMed ID: 24418832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.